MNOV logo

MediciNova, Inc.

MNOV
Healthcare|Biotechnology|US
$1.46
+0.01 (+0.69%)
DCF Value
$0.61
Tangible Book / Share
$0.46
Cash / Share
$0.52
Next Earnings Report
Nov 12, 2026
EPS est. -$0.06 · Revenue est. $50.0K
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Dec 30, 2025 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Dec 2026
Est. completion
P2Diabetes Mellitus, Type 2
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia
NCT05464784n=40
Apr 2027
Est. completion
P2P3Amyotrophic Lateral Sclerosis
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
NCT04057898n=234

Recent Press Releases

MediciNova to Participate in the Maxim Growth Summit
Oct 6, 2026 · GlobeNewsWire
MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Sep 28, 2026 · GlobeNewsWire
MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)
Sep 24, 2026 · GlobeNewsWire
MediciNova to Participate in Two Investor Conferences in September
Sep 8, 2026 · GlobeNewsWire

SEC Filings (32)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 29, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 28, 20268-KMaterial eventDocumentIndex
Sep 2, 20268-KMaterial eventDocumentIndex
Aug 19, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Jun 24, 20268-KMaterial eventDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 20, 2026PRER14ADocumentIndex
Apr 17, 2026PRE 14AProxy / shareholder voteDocumentIndex
Mar 10, 202610-KAnnual reportDocumentIndex
Feb 20, 20268-KMaterial eventDocumentIndex
Dec 30, 2025424B5Offering prospectusDocumentIndex
Dec 30, 20258-KMaterial eventDocumentIndex
Dec 11, 2025EFFECTDocumentIndex
Dec 5, 2025S-3Shelf registrationDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Sep 30, 2025EFFECTDocumentIndex
Aug 22, 2025S-1IPO / offering registrationDocumentIndex
Aug 14, 202510-QQuarterly reportDocumentIndex
Aug 1, 20258-KMaterial eventDocumentIndex
Jun 18, 20258-KMaterial eventDocumentIndex
May 13, 202510-QQuarterly reportDocumentIndex
Apr 28, 2025ARSAnnual report to holdersDocumentIndex
Apr 28, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 28, 2025DEF 14AProxy / shareholder voteDocumentIndex
Mar 11, 20258-KMaterial eventDocumentIndex
Feb 19, 202510-KAnnual reportDocumentIndex
Nov 13, 202410-QQuarterly reportDocumentIndex